An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome

被引:12
|
作者
Suerink, Manon [1 ]
Rodriguez-Girondo, Mar [2 ]
van der Klift, Heleen M. [1 ]
Colas, Chrystelle [3 ,4 ]
Brugieres, Laurence [5 ]
Lavoine, Noemie [5 ]
Jongmans, Marjolijn [6 ,7 ,8 ]
Capella Munar, Gabriel [9 ]
Evans, D. Gareth [10 ]
Farrell, Michael P. [11 ]
Genuardi, Maurizio [12 ,13 ]
Goldberg, Yael [14 ]
Gomez-Garcia, Encarna [15 ]
Heinimann, Karl [16 ,17 ]
Hoell, Jessica, I [18 ]
Aretz, Stefan [19 ,20 ]
Jasperson, Kory W. [21 ]
Kedar, Inbal [14 ]
Modi, Mitul B. [22 ,23 ]
Nikolaev, Sergey [24 ]
van Os, Theo A. M. [25 ]
Ripperger, Tim [26 ]
Rueda, Daniel [27 ]
Senter, Leigha [28 ]
Sjursen, Wenche [29 ,30 ]
Sunde, Lone [31 ]
Therkildsen, Christina [32 ]
Tibiletti, Maria G. [33 ,34 ]
Trainer, Alison H. [35 ]
Vos, Yvonne J. [36 ]
Wagner, Anja [37 ]
Winship, Ingrid [38 ]
Wimmer, Katharina [39 ]
Zimmermann, Stefanie Y. [40 ]
Vasen, Hans F. [41 ]
van Asperen, Christi J. [1 ]
Houwing-Duistermaat, Jeanine J. [2 ]
ten Broeke, Sanne W. [1 ,36 ]
Nielsen, Maartje [1 ]
机构
[1] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands
[3] Paris Sci Lettres Res Univ, Inst Curie, Dept Genet, Paris, France
[4] UPMC Univ Paris 06, Sorbonne Univ, Ctr Rech St Antoine, INSERM,CNRS, Paris, France
[5] Child & Adolescent Canc Dept, Gustave Roussy Canc Campus, Villejuif, France
[6] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands
[7] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[8] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
[9] Catalan Inst Oncol, Lab Recerca Translac, Barcelona, Spain
[10] Univ Manchester, St Marys Hosp, Div Evolut & Genom Med, MAHSC, Manchester, Lancs, England
[11] Mater Private Hosp, Dept Canc Genet, Dublin, Ireland
[12] Fdn Policlin Univ A Gemelli IRCCS, UOC Genet Med, Rome, Italy
[13] Univ Cattolica Sacro Cuore, Ist Med Genom, Rome, Italy
[14] Rabin Med Ctr, Raphael Recanati Genet Inst, Petah Tiqwa, Israel
[15] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands
[16] Univ Basel, Dept Biomed, Res Grp Human Genom, Basel, Switzerland
[17] Univ Hosp Basel, Med Genet, Basel, Switzerland
[18] Heinrich Heine Univ, Univ Childrens Hosp, Med Fac, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany
[19] Univ Bonn, Inst Human Genet, Bonn, Germany
[20] Univ Hosp Bonn, Ctr Hereditary Tumor Syndromes, Bonn, Germany
[21] Ambry Genet, Aliso Viejo, CA USA
[22] Univ Penn Hlth Syst, Penn Hosp, Philadelphia, PA USA
[23] BJ Med Coll, Gujarat Canc & Res Inst, Ahmadabad, Gujarat, India
[24] Univ Paris Saclay, Inserm U981, Gustave Roussy Canc Campus, Villejuif, France
[25] Amsterdam UMC, Locatie AMC, Dept Clin Genet, Amsterdam, Netherlands
[26] Hannover Med Sch, Dept Human Genet, Hannover, Germany
[27] Univ Hosp Doce Octubre, Hereditary Canc Lab, I 12 Res Inst, Madrid, Spain
[28] Ohio State Univ, Div Human Genet, Comprehens Canc Ctr, Columbus, OH 43210 USA
[29] St Olavs Univ Hosp, Dept Med Genet, Trondheim, Norway
[30] Norwegian Univ Sci & Technol, Trondheim, Norway
[31] Aarhus Univ Hosp, Dept Clin Genet, Skejby, Denmark
[32] Copenhagen Univ Hosp, Clin Res Ctr, HNPCC Register, Hvidovre, Denmark
[33] Osped Circolo ASST Settelaghi, Dept Pathol, Varese, Italy
[34] Univ Insubria, Ctr Ric Studio Tumori Eredo Familiari, Varese, Italy
[35] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia
[36] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands
[37] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands
[38] Univ Melbourne, Royal Melbourne Hosp, Genom Med, Melbourne, Vic, Australia
[39] Med Univ Innsbruck, Div Human Genet, Innsbruck, Austria
[40] Univ Hosp, Pediat Hematol & Oncol, Frankfurt, Germany
[41] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands
关键词
HNPCC; colon cancer risk; PMS2; MSH6; bMMRD; DNA MISMATCH REPAIR; GERMLINE MUTATIONS; MICROSATELLITE INSTABILITY; FREQUENCY; AGE; SURVEILLANCE; CRITERIA; PHENOTYPE; FAMILIES; BREAST;
D O I
10.1038/s41436-019-0577-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Biallelic pathogenic variants in the mismatch repair (MMR) genes cause a recessive childhood cancer predisposition syndrome known as constitutional mismatch repair deficiency (CMMRD). Family members with a heterozygous MMR variant have Lynch syndrome. We aimed at estimating cancer risk in these heterozygous carriers as a novel approach to avoid complicated statistical methods to correct for ascertainment bias. Methods: Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards. Confidence intervals (CIs) were obtained by bootstrapping at the family level. Results: The estimated cumulative colorectal cancer risk at age 70 years for heterozygous PMS2 variant carriers was 8.7% (95% CI 4.3-12.7%) for both sexes combined, and 9.9% (95% CI 4.9-15.3%) for men and 5.9% (95% CI 1.6-11.1%) for women separately. For heterozygous MSH6 variant carriers these estimates are 11.8% (95% CI 4.5-22.7%) for both sexes combined, 10.0% (95% CI 1.83-24.5%) for men and 11.7% (95% CI 2.10-26.5%) for women. Conclusion: Our findings are consistent with previous reports that used more complex statistical methods to correct for ascertainment bias. These results underline the need for MMR gene-specific surveillance protocols for Lynch syndrome.
引用
收藏
页码:2706 / 2712
页数:7
相关论文
共 50 条
  • [1] Physical activity and the risk of colorectal cancer in Lynch syndrome
    Dashti, S. Ghazaleh
    Win, Aung Ko
    Hardikar, Sheetal S.
    Glombicki, Stephen E.
    Mallenahalli, Sheila
    Thirumurthi, Selvi
    Peterson, Susan K.
    You, Y. Nancy
    Buchanan, Daniel D.
    Figueiredo, Jane C.
    Campbell, Peter T.
    Gallinger, Steven
    Newcomb, Polly A.
    Potter, John D.
    Lindor, Noralane M.
    Le Marchand, Loic
    Haile, Robert W.
    Hopper, John L.
    Jenkins, Mark A.
    Basen-Engquist, Karen M.
    Lynch, Patrick M.
    Pande, Mala
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (09) : 2250 - 2260
  • [2] Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome
    Ouakrim, Driss Ait
    Dashti, Seyedeh Ghazaleh
    Chau, Rowena
    Buchanan, Daniel D.
    Clendenning, Mark
    Rosty, Christophe
    Winship, Ingrid M.
    Young, Joanne P.
    Giles, Graham G.
    Leggett, Barbara
    Macrae, Finlay A.
    Ahnen, Dennis J.
    Casey, Graham
    Gallinger, Steven
    Haile, Robert W.
    Le Marchand, Loic
    Thibodeau, Stephen N.
    Lindor, Noralane M.
    Newcomb, Polly A.
    Potter, John D.
    Baron, John A.
    Hopper, John L.
    Jenkins, Mark A.
    Win, Aung Ko
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (09)
  • [3] Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer
    Jenkins, Mark A.
    Buchanan, Daniel D.
    Lai, John
    Makalic, Enes
    Dite, Gillian S.
    Win, Aung K.
    Clendenning, Mark
    Winship, Ingrid M.
    Hayes, Richard B.
    Huyghe, Jeroen R.
    Peters, Ulrike
    Gallinger, Steven
    Le Marchand, Loic
    Figueiredo, Jane C.
    Pai, Rish K.
    Newcomb, Polly A.
    Church, James M.
    Casey, Graham
    Hopper, John L.
    [J]. JNCI CANCER SPECTRUM, 2021, 5 (02)
  • [4] Lynch Syndrome: Immune Microenvironment as a Risk Factor for Colorectal Cancer
    不详
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (07): : 1073 - +
  • [5] RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome
    Tuccori, Marco
    Filion, Kristian B.
    Azoulay, Laurent
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (02)
  • [6] Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome
    Duenas, Nuria
    Klinkhammer, Hannah
    Bonifaci, Nuria
    Spier, Isabel
    Mayr, Andreas
    Hassanin, Emadeldin
    Diez-Villanueva, Anna
    Moreno, Victor
    Pineda, Marta
    Maj, Carlo
    Capella, Gabriel
    Aretz, Stefan
    Brunet, Joan
    [J]. JOURNAL OF MEDICAL GENETICS, 2023, 60 (11) : 1044 - 1051
  • [7] Colorectal cancer screening in Lynch syndrome
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (10): : 667 - 667
  • [8] Aspirin, Lynch Syndrome, and Colorectal Cancer
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (03) : 405 - 405
  • [9] Lynch syndrome in colorectal cancer patients
    Dolores Giradez, M.
    Castellvi-Bel, Sergi
    Balaguer, Francesc
    Gonzalo, Victoria
    Ocana, Teresa
    Castells, Antoni
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) : 573 - 583
  • [10] Screening for Lynch syndrome in colorectal cancer
    刘晓红
    [J]. China Medical Abstracts (Internal Medicine), 2014, 31 (03) : 178 - 179